Literature DB >> 17117291

From mild to severe primary hyperparathyroidism: The Brazilian experience.

Francisco Bandeira1, Luiz Griz, Gustavo Caldas, Cristina Bandeira, Eduardo Freese.   

Abstract

Primary hyperparathyroidism often presents as an asymptomatic disorder. In our institution, routine serum calcium measurements have now been used as part of medical examination for 23 years. Out of 124 patients consecutively seen at our institution, 47% presented with no symptoms related to the disease, while 25% presented with severe skeletal involvement and osteitis fibrosa cystica, 25% with renal stone disease without overt bone involvement, and 2% with the typical neuropsychiatric syndrome. This same pattern is seen in the city of São Paulo. In severe disease pathological fractures are frequently seen, especially in long bones of the lower extremities, and also loss of lamina dura of the teeth and salt-and-pepper appearance of the skull. Bone mineral density is extremely low in these patients but usually show remarkable recovery following surgical cure. Serum PTH and bone markers are considerable higher in severely affected patients, who also have a high rate of vitamin D deficiency, and the parathyroid lesion is easier located compared with asymptomatic patients. From pathological specimens 87% had histological confirmation of a single adenoma, 6.4% multiple gland hyperplasia and 3.8% carcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117291     DOI: 10.1590/s0004-27302006000400011

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  13 in total

Review 1.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

Review 2.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 3.  Primary hyperparathyroidism.

Authors:  Tarıq Madkhali; Amal Alhefdhi; Herbert Chen; Dawn Elfenbein
Journal:  Ulus Cerrahi Derg       Date:  2016-03-01

4.  Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.

Authors:  Marcella D Walker; Elaine Cong; Anna Kepley; Marco R Di Tullio; Tatjana Rundek; Shunichi Homma; James A Lee; Rui Liu; Polly Young; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

Review 5.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

Review 6.  Hyperparathyroidism and malnutrition with severe vitamin D deficiency.

Authors:  Amit Agarwal; Sushil Kumar Gupta; Ranjith Sukumar
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 7.  Bone disease in primary hyperparathyroidism.

Authors:  Francisco Bandeira; Natalie E Cusano; Barbara C Silva; Sara Cassibba; Clarissa Beatriz Almeida; Vanessa Caroline Costa Machado; John P Bilezikian
Journal:  Arq Bras Endocrinol Metabol       Date:  2014-07

8.  Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Shonni J Silverberg; Bart L Clarke; Munro Peacock; Francisco Bandeira; Stephanie Boutroy; Natalie E Cusano; David Dempster; E Michael Lewiecki; Jian-Min Liu; Salvatore Minisola; Lars Rejnmark; Barbara C Silva; Marcella D Walker; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958

9.  Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry.

Authors:  Ashutosh Kumar Arya; Poonam Kumari; Sanjay Kumar Bhadada; Kanhaiya Agrawal; Priyanka Singh; Soham Mukherjee; Ashwani Sood; Sudhaker D Rao
Journal:  J Bone Miner Metab       Date:  2020-09-07       Impact factor: 2.626

10.  Isolated hypophosphataemia as an early marker of primary hyperparathyroidism.

Authors:  John Alexander; Dinesh Nagi
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.